Home › Pancreatic Cancer › NCT05743049
Collection of Circulating Biomarkers in Pancreatic Cancer
RecruitingObservational study
Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma * The subject must be a patient of the University of Pennsylvania * The subject must be able to provide informed consent * The subject must be 18 years of age or older Exclusion Criteria: . Subjects who have any clinically significant psychiatric, social, or medical condition that, in the opinion of the investigator, could increase the patient's risk, interfere with protocol adherence, or affect the patient's ability to give informed consent are ineligible to participate in the study.
About the study
This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.
What is being tested
- Obtaining blood for analysis of various circulating biomarkers (other)
Sponsor: Abramson Cancer Center at Penn Medicine · Participants: 30 · Started: Feb 27, 2023
Contact the study team
- Liudmila Mazaleuskaya, PhD · Phone: 267-455-9141
- Mark O'Hara, MD · Phone: 215-360-0919
Official record on ClinicalTrials.gov — NCT05743049
Locations in the U.S.
| Pennsylvania | Abramson Cancer Center at University of Pennsylvania, Philadelphia |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.